These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24133918)

  • 1. Establishment of tacrolimus-induced diabetes in rat model and assessment of clinical treatments for post-transplant diabetes mellitus in liver transplant recipients.
    Niu YJ; Shen ZY; Xu C; Li CF; Liu XJ; Teng YQ; Chen H; Li L; Cheng HM; Yang XM; Mao S
    Clin Lab; 2013; 59(7-8):869-74. PubMed ID: 24133918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience.
    Xu X; Ling Q; He ZL; Gao F; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):465-70. PubMed ID: 18842490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin Secretion and Insulin Resistance Trajectories over 1 Year after Kidney Transplantation: A Multicenter Prospective Cohort Study.
    Bang JB; Oh CK; Kim YS; Kim SH; Yu HC; Kim CD; Ju MK; So BJ; Lee SH; Han SY; Jung CW; Kim JK; Lee SH; Jeon JY
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):820-829. PubMed ID: 33202516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating mechanisms of post-transplant diabetes mellitus.
    van Hooff JP; Christiaans MH; van Duijnhoven EM
    Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi8-vi12. PubMed ID: 15575024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplant diabetes mellitus. The role of immunosuppression.
    Jindal RM; Sidner RA; Milgrom ML
    Drug Saf; 1997 Apr; 16(4):242-57. PubMed ID: 9113492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New onset diabetes and impaired fasting glucose after liver transplant: risk analysis and the impact of tacrolimus dose.
    Lankarani KB; Eshraghian A; Nikeghbalian S; Janghorban P; Malek-Hosseini SA
    Exp Clin Transplant; 2014 Feb; 12(1):46-51. PubMed ID: 23902591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
    Handisurya A; Kerscher C; Tura A; Herkner H; Payer BA; Mandorfer M; Werzowa J; Winnicki W; Reiberger T; Kautzky-Willer A; Pacini G; Säemann M; Schmidt A
    PLoS One; 2016; 11(1):e0145319. PubMed ID: 26735686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus after living donor liver transplantation: data from mainland China.
    Zhao J; Yan L; Li B; Zeng Y; Wen T; Zhao J; Wang W; Xu M; Yang J; Ma Y; Chen Z; Wu H; Wei Y
    Transplant Proc; 2009 Jun; 41(5):1756-60. PubMed ID: 19545722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.
    Lancia P; Adam de Beaumais T; Elie V; Garaix F; Fila M; Nobili F; Ranchin B; Testevuide P; Ulinski T; Zhao W; Deschênes G; Jacqz-Aigrain E
    Pediatr Nephrol; 2018 Jun; 33(6):1045-1055. PubMed ID: 29399716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
    Sato T; Inagaki A; Uchida K; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Tominaga Y; Okajima Y; Ohta K; Suga H; Taguchi S; Kakiya S; Itatsu T; Kobayashi T; Nakao A
    Transplantation; 2003 Nov; 76(9):1320-6. PubMed ID: 14627910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: results of a pilot study.
    Lorho R; Hardwigsen J; Dumortier J; Pageaux GP; Durand F; Bizollon T; Blanc AS; Di Giambattista F; Duvoux C
    Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):482-8. PubMed ID: 21530445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic aspects of tacrolimus in renal transplantation. Consequences for the choice of an immunosuppressive regimen and for the management of post-transplant diabetes mellitus.
    van Duijnhoven EM; Boots JM; Christiaans MH; van Hooff JP
    Minerva Urol Nefrol; 2003 Mar; 55(1):33-42. PubMed ID: 12773965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and meta-analysis of post-transplant diabetes mellitus in liver transplant recipients.
    Lawendy B; Srinathan S; Kotha S; Gomes C; Misra S; Yu J; Orchanian-Cheff A; Tomlinson G; Bhat M
    Clin Transplant; 2021 Jul; 35(7):e14340. PubMed ID: 34033142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors Associated With New-Onset Diabetes After Liver Transplant: A Case Control Study.
    Terto SV; Araújo ST; Negreiros FDDS; Brasil BMBL; da Cunha GH; Rodrigues AB; de Carvalho MMD; Gadelha DD; Carioca AAF; Oliveira Fernandes V; Montenegro Júnior RM
    Transplant Proc; 2019; 51(6):1956-1961. PubMed ID: 31303408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher tacrolimus blood concentration is related to increased risk of post-transplantation diabetes mellitus after living donor liver transplantation.
    Song JL; Li M; Yan LN; Yang JY; Yang J; Jiang L
    Int J Surg; 2018 Mar; 51():17-23. PubMed ID: 29360611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on: New-onset diabetes and impaired fasting glucose after a liver transplant: risk analysis and the effect of tacrolimus dosage.
    Kabir A
    Exp Clin Transplant; 2014 Feb; 12(1):85. PubMed ID: 24471727
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to: Comment on: New-onset diabetes and impaired fasting glucose after liver transplant: risk analysis and the impact of tacrolimus dose.
    Lankarani KB; Nikeghbalian S; Janghorban P; Malek-Hosseini SA
    Exp Clin Transplant; 2014 Feb; 12(1):86. PubMed ID: 24471728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.